SCHEMBL7882154

SCHEMBL7882154

CNC(N)=NC(=O)c1cc2c(Cl)cc(OCc3ccccc3CN)cc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RHEB Q15382 3/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HDAC8 Q9BY41 1/20 0.32
NR4A2 P43354 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
BRD4 O60885 1/20 0.32
BACE1 P56817 1/20 0.32
GRIN1 Q05586 1/20 0.31
SLC26A4 O43511 1/20 0.31
PDK2 Q15119 1/20 0.31
CFD P00746 1/20 0.31
HTR1A P08908 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873845 0.90 SLC6A4 (0.34) RHEBMAOAMAOBMEN1KMT2A
SCHEMBL7885059 0.88 MDM4 (0.33) KDM4ESMN1; SMN2RHEBMAOAMAOB
SCHEMBL7882032 0.87 MAOB (0.39) KDM4ESMN1; SMN2RHEBMAOAMAOB
SCHEMBL7880770 0.87 CYP3A4 (0.40) RHEBMEN1KMT2ANPC1RAB9A
SCHEMBL7881424 0.87 MAOB (0.36) RHEBMAOAMAOB
SCHEMBL7877991 0.86 MAOB (0.38) MAOAMAOBCFD
Hydrochloric Acid SCHEMBL7879402 0.86 MAOB (0.37) RHEBMAOAMAOB
SCHEMBL7884907 0.85 FLT3 (0.43) KDM4ESMN1; SMN2MEN1KMT2ANPC1
SCHEMBL7882066 0.84 TDP1 (0.34) SMN1; SMN2RHEBMEN1KMT2ANPC1
SCHEMBL7873935 0.84 FFAR1 (0.31) RHEBGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed